CACLP - The largest IVD Expo & Conference

RNA Sequencing Can Increase Diagnostic Rate for Rare Diseases

Industry news | 13 June, 2023 | CACLP

Original from: Inside Precision Medicine

 

Results from the 100,000 Genomes cohort in the U.K. show that RNA sequencing has the potential to increase the number of diagnoses given to individuals with rare disease.

 

The researchers predict that over 20% of people in the cohort who did not achieve a diagnosis with genome or exome sequencing can achieve one by using this method.

 

Jenny Lord, a senior research fellow in computational biology at the University of Southampton, reported the results of this analysis at the European Society of Human Genetics conference in Glasgow this week.

 

“The diagnosis of rare disorders has really been revolutionized in recent years through the likes of whole exome and whole genome sequencing. But even with whole genome sequencing, about half of patients don’t get a diagnosis,” she explained.

 

“A lot of this has to do with the fact that our ability to generate this data has really outstripped our ability to interpret it. RNA sequencing gives us a way to get around this interpretation bottleneck, and see what’s actually being produced from the gene at the RNA level. We can look for places where a patient is different from controls, or from other patients, in terms of expression or splicing, and link that back to changes in the DNA and ultimately make diagnoses for patients.”

 

Lord and colleagues analyzed whole blood-based RNA sequencing data from 4400 individuals who participated in the 100,000 Genomes Project, which began in 2012. Of this group, 36% have some form of neurodevelopmental disorder, 49% are female and 70% are from White European ancestry. The people in this group previously failed to receive a diagnosis of their condition after standard whole genome sequencing.

 

Gene expression outliers were identified by OUTRIDER via DROP and splicing outliers were mostly identified using LeafCutterMD. Overall, an average of 5.4 expression and 5.3 splicing outliers were found across the genome of each participant tested. When these were limited to panels of relevant genes, this dropped to 0.2 expression and 0.2 splicing outliers per person tested.

 

For example, a splicing outlier was found in the PTEN gene, which is linked to Cowden syndrome. On the expression side, an outlier was found for the RPL5 gene, which is linked to Diamond-Blackfan anemia.

 

“We’ve already been able to identify many expression and splicing outliers, some of which we already think are diagnostic, and the work on this is ongoing,” explained Lord, who added that there is lots of analysis still to be done.

 

“Our early estimates say that we should find one of these candidate diagnostic events in about 25% of the cohort, which has the potential to make a huge impact on diagnostic rate.”

Source: RNA Sequencing Can Increase Diagnostic Rate for Rare Diseases

 

Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference